| 000 | 01810cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030340.0 | ||
| 008 | 110123s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.04.M.Sc.2010.Mo.E | ||
| 100 | 0 | _aMohamed Abdelfatah Imam | |
| 245 | 1 | 0 |
_aEverolimus eluting stent; short term clinical follow up in patients with acute coronary syndrome / _cMohamed Abdelfatah Imam ; Supervised Soliman Gharib Ibrahim , Mohamed Mahmoud Abd El Ghany , Hossam El Din Ghanem El Hossary |
| 246 | 1 | 5 | _aمتابعة اكلينيكية قصيرة المدى للدعامة الدوائية بالافيروليمس فى مرضى قصور الشرايين التاجية الحادة |
| 260 |
_aCairo : _bMohamed Abdelfatah Imam , _c2010 |
||
| 300 |
_a110 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology | ||
| 520 | _aIn Egypt the most common use for drug eluting stent is the off label category and whether there is a difference between the off label category and the on label category for the patient with acute coronary syndromes (ACS) in the short term follow up. To determine the difference between the on label and the off label use of everolimus eluting stent | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute coronary syndrome | |
| 653 | 4 | _aCoronary heart disease | |
| 653 | 4 | _aEverolimus eluting stent | |
| 700 | 0 |
_aHossam Eldin Ghanem Elhossary , _eSupervisor |
|
| 700 | 0 |
_aMohamed Mahmoud Abdelghany , _eSupervisor |
|
| 700 | 0 |
_aSoliman Gharib Ibrahim , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c32842 _d32842 |
||